» Articles » PMID: 14527431

Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2003 Oct 7
PMID 14527431
Citations 264
Authors
Affiliations
Soon will be listed here.
Abstract

We tested whether proteins implicated in Huntington's and other polyglutamine (polyQ) expansion diseases can cause axonal transport defects. Reduction of Drosophila huntingtin and expression of proteins containing pathogenic polyQ repeats disrupt axonal transport. Pathogenic polyQ proteins accumulate in axonal and nuclear inclusions, titrate soluble motor proteins, and cause neuronal apoptosis and organismal death. Expression of a cytoplasmic polyQ repeat protein causes adult retinal degeneration, axonal blockages in larval neurons, and larval lethality, but not neuronal apoptosis or nuclear inclusions. A nuclear polyQ repeat protein induces neuronal apoptosis and larval lethality but no axonal blockages. We suggest that pathogenic polyQ proteins cause neuronal dysfunction and organismal death by two non-mutually exclusive mechanisms. One mechanism requires nuclear accumulation and induces apoptosis; the other interferes with axonal transport. Thus, disruption of axonal transport by pathogenic polyQ proteins could contribute to early neuropathology in Huntington's and other polyQ expansion diseases.

Citing Articles

A method for the analysis of the oligomerization profile of the Huntington's disease-associated, aggregation-prone mutant huntingtin protein by isopycnic ultracentrifugation.

Bonavita R, Di Martino R, Cortone G, Prodomo A, Di Gennaro M, Scerra G Front Mol Biosci. 2024; 11:1420691.

PMID: 38993838 PMC: 11236693. DOI: 10.3389/fmolb.2024.1420691.


Transient interdomain interactions modulate the monomeric structural ensemble and self-assembly of Huntingtin Exon 1.

Mohanty P, Phan T, Mittal J bioRxiv. 2024; .

PMID: 38766024 PMC: 11100600. DOI: 10.1101/2024.05.03.592468.


Epigenetic editing for autosomal dominant neurological disorders.

Waldo J, Halmai J, Fink K Front Genome Ed. 2024; 6:1304110.

PMID: 38510848 PMC: 10950933. DOI: 10.3389/fgeed.2024.1304110.


The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease.

Perot J, Brouillet E, Flament J Front Aging Neurosci. 2024; 16:1306312.

PMID: 38414634 PMC: 10896846. DOI: 10.3389/fnagi.2024.1306312.


Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.

Ueda T, Takeuchi T, Fujikake N, Suzuki M, Minakawa E, Ueyama M Acta Neuropathol Commun. 2024; 12(1):20.

PMID: 38311779 PMC: 10840176. DOI: 10.1186/s40478-024-01729-8.